Jazz Pharmaceuticals Adopts Hybrid Model Using ³Ô¹Ï±¬ÁÏ eTMF and CTMS

"Having CTMS and eTMF in the ³Ô¹Ï±¬ÁÏ Clinical Platform is an advantage because as soon as the monitoring report is created in CTMS, it's added to a workflow and automatically filed in eTMF once approved."

- Andrew Lee, Senior Manager, GCDO Business & Technology, Jazz Pharmaceuticals

Jazz Pharmaceuticals provides an overview of its clinical operations journey and how the company uses ³Ô¹Ï±¬ÁÏ eTMF and ³Ô¹Ï±¬ÁÏ CTMS to support its hybrid CRO model.